Clinical Research Directory
Browse clinical research sites, groups, and studies.
Taurine Eye Drops May Prevent the Progression of Cataract
Sponsor: University Of Anbar
Summary
The aim of the current intervention study is to determine the effectiveness of taurine containing eye drops (available under brand name VIZILOTON) to prevent the progression of grade I and II senile cataract. This study could answer: * Dose continuous use of taurine-containing eye drops could prevent further deterioration of vision in mild cases of cataract? * The acceptance/ compliance of participants to taurine-containing eye drops. * Could long-term use of taurine-containing eye drops cause adverse effect(s)? Participants will: * Take taurine-containing eye drops (VIZILOTON eye drops) 4 times a day for one year. * Visit eye clinic every 3 months for assessment and visual examination. * Keep notes for their symptoms and their adherence to treatment.
Official title: Taurine Affects the Progression of Senile Cataract: a Single-arm Pre-post Intervention Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2023-07-10
Completion Date
2024-12-20
Last Updated
2024-12-09
Healthy Volunteers
No
Conditions
Interventions
Taurine
Taurine-containing eye drops (VIZILOTON) are applied 4 times daily for a period of one year
Locations (1)
Al-Nahrain Eye Clinics
Ramadi, Al-Anbar Governorate, Iraq